Generalized anxiety disorder: raising the expectations of treatment.

摘要: Anxiety disorders are prevalent and associated with an increase in morbidity mortality, particularly when present additional psychiatric disorders. They represent a public health economic burden, yet they commonly underrecognized undertreated. Benzodiazepines effective anxiolytics, but primarily treat the somatic symptoms of generalized anxiety disorder (GAD), not treating depressive that often comorbid chronic like GAD. Some antidepressants may therefore offer best choice therapy. Their benefit treatment GAD has been demonstrated using tricyclic antidepressant, imipramine, some selective serotonin reuptake inhibitors. The norepinephrine inhibitor venlafaxine extended release (XR), indicated for proven to be both short- long-term patients this disorder. Many treated XR achieve sustain remission from GAD, which is goal treatment.